Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: Study of the ETX-4143 2.0 Device in Subjects With Eye Pain [NA]

View source ↗

Summary

Clinical trial update indicates the ETX-4143 2.0 Device study in subjects with eye pain has been completed. Sponsor: EyeCool Therapeutics, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ETX-4143 2.0 Device

Snippet

Sponsor: EyeCool Therapeutics, Inc. | Conditions: Eye Pain | NA | Status: COMPLETED